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Background: In 2009, a pandemic associated with a new type of influenza A virus (H1N1) affected many countries worldwide. After five 
years of silence, in 2015 we encountered another outbreak of H1N1 influenza A.
Objectives: The present study aimed to study the epidemiological and clinical features of this disease in the cold and dry climate of Qazvin 
province, Iran in the last epidemic, during 2009.
Patients and Methods: This was a cross-sectional study in which the demographic characteristics and clinical manifestations of 
confirmed cases of influenza A virus (H1N1) in the province of Qazvin were investigated. The definite diagnosis of cases was performed 
using real time Polymerase Chain Reaction (PCR) on oropharyngeal washing specimens from adults and throat swabs from children and 
severely ill patients.
Results: During the time course between July to December 2009, 76 confirmed cases of influenza A (H1N1) were discovered in the province 
of Qazvin. The mean age of patients was 25.67 ± 16.9 years. The most affected people were students and housewives. Coughing was found to 
be the most common clinical symptom (96.1%) followed by fever (92.1%), myalgia (48.5%), and diarrhea and vomiting (34.2%). In laboratory 
confirmed patients, 62 were hospitalized and two cases deceased. Regarding the total population of the Qazvin province (1,100,000), 
the rate of hospitalization was calculated at 5.42 per 100,000 individuals, with a mortality rate of 0.175 per 100,000 individuals (3.2% of 
hospitalized cases).
Conclusions: Concerning the higher prevalence of disease in younger age groups, and more severe disease in high-risk groups, including 
overweight patients and pregnant women, the authors recommend special attention to clinical symptoms such as diarrhea and vomiting, 
cough, myalgia and fever in patients with cold symptoms. Also, for severely ill patients, the allocation of adequate intensive care units 
should be of prime importance.
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1. Background
In 2009 the world experienced the emergence of a 
pandemic associated with a new type of influenza with 
a genetic arrangement that was never seen in viruses iso-
lated from humans or animal sources (1, 2). By the 20th 
of September 2009, cases of disease were reported from 
191 countries worldwide (3). This virus contains gene seg-
ments from human, swine, and avian influenza viruses 
(4). Although some authorities believe in exaggeration of 
the extent of danger of the 2009 pandemic flu, later stud-
ies did not show evidence of “media over-hyping” in the 
swine flu pandemic (5). Due to the extremely widespread 
transmission of the disease in societies, even with exten-
sive sampling, it was impossible to estimate the real num-
ber of infected people (6). Therefore, from the July 2009 
sampling of all suspected cases was discontinued and 
samples were taken only from those with severe disease. 
The first confirmed case of the disease in the province of 
Qazvin was discovered in July 2009 followed by another 
75 laboratory-proven cases within the whole province af-
terwards. In subsequent years cases of influenza A (H1N1) 
were scant, yet after five years another outbreak emerged 
in 2015. The province of Qazvin with a population of 1 143 
178 (according to the latest national census) is located 
on the southern margin of the Alborz mountain ranges 
within a latitude between 35° 24’ and 36° 48’ N with a cold 
and dry climate.
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2. Objectives
The present study aimed to evaluate the epidemiologi-
cal and clinical aspects of this disease during the last 
epidemic within the cold and dry climate of the Qazvin 
province.
3. Patients and Methods
This was a cross-sectional study performed in the prov-
ince of Qazvin during the time course between October 
and February 2009. Samples were taken from all patients 
with severe clinical symptoms of influenza who had vis-
ited the health centers within the entire province of Qa-
zvin. Specimens were obtained through oropharyngeal 
gargling of Dulbecco's Modified Eagle's Medium (DMEM) 
in adult patients, and throat swab in children and severe-
ly ill patients. Samples, while in viral transport medium, 
were transferred to the molecular diagnostic department 
of the reference laboratory of the province. The samples 
were kept at -70°C until laboratory analysis. Viral RNA 
extraction was performed using commercial kits (High 
Pure Viral RNA, Qiagen and Roche Co, USA). Laboratory 
diagnosis of the causative agent was performed by Real 
Time-Polymerase Chain Reaction (RT-PCR) using two step 
PCR kits (Qiagen and Invitrogen Co, USA) and application 
of the World Health Organization (WHO) defined sets of 
primers and probes specific for universal influenza A, 
swine influenza A and swine H1N1 (sequences are shown 
in Table 1). Later, using the RT-PCR technique and AB1 7500 
instrument, the target sequences were amplified and the 
Cycle Threshold (CT) value was automatically recorded 
and the results were qualitatively reported for each set 
of reactions. Those specimens that gave positive CTs with 
each set of primers and probes for universal influenza A, 
swine influenza A, and swine H1N1, were considered as 
positive. Demographic characteristics and clinical signs 
of all patients were recorded. For those complaining of 
dyspnea, pulse oximetry was performed, and arterial oxy-
gen saturation of less than 90%, during the course of the 
disease, was considered as hypoxemia. Also, the height 
and weight of patients were measured while the Body 
Mass Index (BMI) was calculated only for those over 18 
years of age, except pregnant women, for whom the BMI 
was not determined. Descriptive data were presented as 
frequencies (percentages) for discrete variables and as 
means (± Standard Deviation) or medians for continu-
ous variables. Univariate analysis of data was performed 
using the chi-square and Fisher’s exact test. A p-value of 
less than 0.05 was considered statistically significant. Epi 
Info ™ 3.5.1 software was used for data analyses.
4. Results
From July to December 2009, a total of 518 patients were 
examined, from whom 76 confirmed cases of pandemic 
influenza A (H1N1) were discovered (Figure 1). Medical 
care was provided for patients through ten hospitals 
within the five cities of the province. During the epi-
demic, school closures took place in different cities of the 
province, during the second half of November 2009. The 
age of patients ranged from two months to 72 years with 
a median of 23 years and a mean age of 25.67 ± 16.9 years. 
Of all patients, 30 were allocated to the under 18-year-old 
group and 46 to the over 18-year-old group. During this 
epidemic most cases (51 patients) of disease were re-
ported from the city of Qazvin and the least (one patient) 
from Abyek (Figure 2). The distribution of demographic 
characteristics, underlying conditions and the clini-
cal symptoms of disease in under 18-year-old and over 
18-year-old age groups are shown in Table 2. In the course 
of disease, 30 patients had hypoxemia (arterial oxygen 
saturation under 90%). The univariate analysis indicated 
that the presence of chronic pulmonary diseases (includ-
ing asthma) and Congestive heart failure (CHF) or valvu-
lar heart disease was associated with hypoxemia in the 
Table 1.  Sequence of Primers and Probes Used for RT-PCR in the Present Study
Primers and Probes Sequence (5’>3’) Working Concentration, µM
InfA
Forward GAC CRA TCC TGT CAC CTC TGA C 40
Reverse AGG GCA TTY TGG ACA AAK CGT CTA 40
Probe TGC AGT CCT CGC TCA CTG GGC ACG 10
SW InfA
Forward GCA CGG TCA GCA CTT ATY CTR AG 40
Reverse GTG RGC TGG GTT TTC ATT TGG TC 40
Probe CYA CTG CAA GCC CA“T” ACA CAC AAG CAG GCA 10
SW H1
Forward GTG CTA TAA ACA CCA GCC TYC CA 40
Reverse CGG GAT ATT CCT TAA TCC TGT RGC 40
Probe CA GAA TAT ACA “T”CC RGT CAC AAT TGG ARA A 10
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course of disease. Also, in our study, BMI was significantly 
higher in the hypoxemic patients (Table 3). Multiple lo-
gistic regression analysis with the mentioned variables, 
showed a significant association between BMI (OR: 1.21, CI: 
1.06-1.38, P = 0.004) and chronic pulmonary diseases (OR: 
4.8, CI: 1.01-23.26, P = 0.048), and hypoxemia in the course 
of Swine-Origin Influenza A (H1N1). Amongst patients with 
confirmed disease, 62 were hospitalized in whom oselta-
mivir was administered as antiviral therapy. The reported 
complications were negligible and limited to nausea and 
vomiting in two patients. In hospitalized patients, 12 were 
admitted to intensive care units and 11 needed assisted ven-
tilation. Also, of the 62 hospitalized patients, 60 (86%) were 
discharged. Two patients (3.2%) died (a 37-year-old man with 
chronic pulmonary disease and a 39-year-old woman with-
out any known co-morbidity). Considering the total num-
ber population within the province, the rate of hospitaliza-
tion was calculated at 5.42 per 100 000 individuals and that 
of mortality rate at 0.175 per 100 000 individuals (3.2% of 
hospitalized cases).
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Figure 1. Seasonal Distribution (Epidemiologic Curve) of Confirmed Cas-
es of Human Infection With Swine-Origin Influenza A (H1N1) Virus in the 
Qazvin Province (July-December 2009)
Figure 2. Regional Distribution of Seventy-Six Confirmed Cases of Hu-
man Infection With Swine-Origin Influenza A (H1N1) Virus in the Qazvin 
Province (July-December 2009)
The figures in brackets indicate the number of cases per 100,000 indi-
viduals, based on the total population of each city according to the lat-
est national census in 2007 (incidence in the Qazvin province: 6.648 per 
100,000 individuals).
Table 2.  Demographic Characteristics, Underlying Conditions 
and Clinical Manifestations of the Study Population (n = 76) a, b
Characteristics Age Group P Value
≤ 18 years > 18 years
Occupation
Worker 0/30 (0.0) 5/45 (11.1) 0.0708
Teacher 0/30 (0.0) 2/45 (4.4) 0.3567
Housekeeper 1/30 (3.3) 18/45 (40.0) 0.0003
Health Care Worker 0/30 (0.0) 2/45 (4.4) 0.3567
Office Employer 0/30 (0.0) 3/45 (6.7) 0.2101
Military 0/30 (0.0) 5/45 (11.1) 0.708
Shop Keeper 0/30 (0.0) 6/45 (13.3) 0.0404
Driver 0/30 (0.0) 2/45 (4.4) 0.03567
Unemployed 29/30 (96.7) 2/45 (4.4) 0.0000
Gender
Female 10/30 (33.3) 21/46 (45.7) 0.2854
Male 20/30 (66.7) 25/46 (54.3) 0.2854
Comorbidities
Asthma or chronic pulmonary 
disease
1/28 (3.6) 11/46 (23.9) 0.0188
CHF or valvular heart disease 3/28 (10.7) 3/46 (6.5) 0.4092
Neurologic and neuromuscular 
disorders
3/28 (10.7) 1/46 (2.2) 0.1488
DM 0/28 (0.0) 9/46 (19.6) 0.0099
Hypertension 0/30 (0.0) 4/46 (8.7) 0.1272
Pregnancy 0/30 (0.0) 3/46 (6.5) 0.2159
Clinical Manifestations
Cough 27/30 (90.0) 46/46 (100.0) 0.0577
Fever 28/30 (93.3) 42/46 (91.3) 0.5556
Myalgia 2/20 (10.0) 30/46 (65.2) 0.0000
Diarrhea 9/30 (30.0) 17/46 (36.9) 0.5321
a  Abbreviations: DM, Diabetes mellitus; CHF, congestive heart failure.
b  Data are presented as No/total No. (%).
Table 3.  Demographic Characteristics and Underlying Medical 
conditions of Patients According to Hypoxemia a,b
Variables Hypoxemic Non Hypoxemic P Value
Continuous Variables
Age 23.3 ± 16.2 29.3 ± 17.6 0.135
BMI 22.2 ± 27.3 27.2 ± 21.3 0.000
Dichotomous variables
Gender, Female 13/30 (43.3) 18/46 (39.1) 0.715
Asthma or chronic 
pulmonary disease
14/30 (46.7) 3/46 (6.5) 0.000
CHF or valvular heart 
disease
8/30 (26.7) 3/46 (6.5) 0.018
Neurologic and 
neuromuscular disorders
2/30 (6.7) 2/46 (4.3) 0.517
DM 5/30 (16.7) 4/46 (8.7) 0.243
Hypertension 3/30 (10.0) 1/46 (2.2) 0.166
Pregnancy 1/33 (3.3) 2/46 (4.3) 0.657
a Abbreviation: DM, Diabetes mellitus; CHF, congestive heart failure.
b Data are presented as No/total No. (%) or Mean ± Standard Deviation (SD).
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5. Discussion
When the first epidemic Influenza A virus (H1N1) was re-
ported from Mexico in the beginning of 2009, there were 
a few known health authorities who could have predict-
ed the emergence of a pandemic. Following numerous 
cases of H1N1-associated influenza A reported from other 
countries in the beginning of summer 2009, the WHO, 
due to widespread human-to-human transmission of 
the disease at least in two countries, announced the 
maximum level of pandemic alert (phase 6 pandemic). 
Gradually, more cases of disease were reported from oth-
er countries including Asian and Middle East countries. 
The rate of confirmed case detection in the Middle East 
was variable; in our study it was 6.65 per 100,000 indi-
viduals. Ahmed et al. reported 18.5 per 100.000 individu-
als in Abu Dhabi, Emirates (7). In Iran, Afrasiabian et al. 
reported 10.5 per 100.000 individuals in the Kurdistan 
province (157 cases in 1 494 000 individuals) (8). In this 
study most cases were reported from northern regions 
of the province with cold climates. The possible reason 
for fewer incidence of disease within the southern re-
gions could be due to a warmer climate, as well as lack 
of adequate resources in case-finding and laboratory 
facilities in these regions. In our study, the rate of hos-
pitalization in pandemic influenza A (H1N1) was 5.42 per 
100,000 individuals, which was less than reports from 
many developed countries (9, 10). It is important to note 
that the rate of hospitalized cases is more related to the 
sensitivity of the health care system and also the avail-
ability of sufficient hospital beds rather than the inci-
dence rate and severity of disease in the community. In 
contrast to the former strains of influenza, patients with 
pandemic influenza A (H1N1) were mostly from younger 
age groups. As reported in some published studies, at 
the beginning of the epidemic within developed coun-
tries, the incidence rate of disease among the age group 
below 18 years was calculated at up to 60% (1). In the Mid-
dle East, Ahmed et al. reported the highest incidence of 
disease in the 15 - 19 year-old age group amongst 344 con-
firmed cases in Abu Dhabi, Emirates (7). In the present 
study, 60.5% of cases were under 25 years old. As shown 
in Figure 1, the epidemiological curve (seasonal distribu-
tion) is indicative of a person-to-person transmission. In 
an experimental study using laboratory animals, the re-
lease of respiratory droplets was confirmed as the prin-
cipal route of transmission (11). In a human study carried 
out in south Asia, wet cough was shown to act as an im-
portant risk factor for transmission of H1N1-2009 virus 
from index cases to household contacts (OR: 1.56, CI: 1.22-
1.99) (12). In a consultation meeting held in the Eastern 
Mediterranean region, large particle droplets were intro-
duced as the main route of transmission of the virus (13). 
Contact with fomites contaminated with respiratory or 
digestive secretions of patients was also considered as a 
route of infection (14). Social distancing such as school 
closures has had a dramatic effect on transmission of 
pandemic influenza (15). It is possible that school clo-
sures in the time interval between 15 and 30 November 
in different cities of the province had an effect on the de-
cline of the incidence of new cases of influenza, as illus-
trated in Figure 1. The symptoms of pandemic influenza A 
(H1N1) were to a great extent similar to those of seasonal 
flu that occurred during the recent years (16). However, 
in the studies reviewing the pandemic, the occurrence of 
gastrointestinal manifestations (diarrhea and vomiting) 
was emphasized (17). As shown in Table 4, except for the 
study of Tang et al. (18) incidence of diarrhea was rela-
tively high in the 2009 influenza pandemic. Although 
most cases with 2009 pandemic influenza were mild and 
self-limiting, yet, about 0.5% of all cases required assisted 
ventilation (1). In most previous studies, the majority of 
patients were children less than five years old, people 
with chronic cardiopulmonary diseases, and pregnant 
women. In our study, despite higher co-morbidity rate 
among hypoxemic patients, the significant difference 
was only found in those with pulmonary co-morbidity. 
However, the presence of underlying diseases, in general, 
was lower (35.5% of hospitalized cases) than that of many 
other similar studies. In a report by Webb et al. from 
Australia and New Zealand on hospitalized patients at 
Intensive Care Units (ICUs) alone, no underlying disease 
was found in 229 (27.9%) cases (19). Also, in another study 
by Louie from the USA, there was no underlying disease 
in 347 patients (32%) out of a total of 1088 individuals 
(20). In the Eastern Mediterranean region, 75% of admit-
ted patients had underlying medical conditions such as 
immunosuppression, heart or lung disease (including 
asthma), diabetes and obesity (13). The lowest number 
of underlying diseases was reported from Mexico, where 
the absence of underlying diseases was proved in 10 cas-
es (55.5%) from a total of 18 confirmed hospitalized cases 
with pandemic influenza (21). In a study on the pediatric 
age group, asthma and neurologic impairment were the 
most prevalent underlying risk factors (22). Regarding 
the role of obesity and being overweight, there are estab-
lished evidences concerning the place of high BMI in se-
verity of disease (19, 23, 24). In our study, BMI was shown 
to be an independent risk factor of Hypoxemia in the 
course of the 2009 pandemic influenza A (H1N1). Consid-
ering the susceptibility of pandemic influenza A (H1N1) 
virus to oseltamivir, as indicated by studies during the 
past epidemics (1, 2), and the recommendation by the 
Infectious Diseases Society of America concerning the 
administration of antiviral drugs for all cases of severe 
influenza (25), all hospitalized cases in this study were 
placed under oseltamivir therapy. In this study, similar 
to some other studies involving hospitalized patients 
with pandemic influenza A (H1N1) (26), the side effects 
were mild and scant. The rate of admission to ICUs was 
reported to be diverse in studies carried out in different 
countries. In a study by Bishop in Australia, the rate of 
admission to ICUs was calculated to be around 3.5/100 
000 individuals (9). Likewise, in another study by Webb 
Bijani B et al.
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Table 4.  Comparison of Clinical Symptoms and Outcome Measures of the Present Study and Studies From Other Countries a
Clinical Symptoms Present Study Study Population Other Articles References
Fever 70/76 (92.1)
Confirmed cases in the United States 371/394 (94.0) (1)
Confirmed inpatient cases in China 287/426 (67.4) (26)
Confirmed inpatient cases in California (USA) 972/1088 (89.0) (20)
Confirmed inpatient cases in Mexico City 18/18 (100.0) (21)
Confirmed cases and close contacts in Singapore 434/547 (79.3) (18)
Cough 73/76 (96.1)
Confirmed cases in the United States 365/397(92.0) (1)
Confirmed inpatient cases in China 296/426 (69.5) (26)
Confirmed inpatient cases in California (USA) 939/1088 (86.0) (20)
Confirmed inpatient cases in Mexico City 18/18(100.0) (21)
Confirmed cases and close contacts in Singapore 482/547 (88.1) (18)
Diarrhea 26/76 (34.2)
Confirmed cases in the United States 82/323 (25.0) (1)
Confirmed inpatient cases in China 12/426 (2.8) (26)
Confirmed inpatient cases in California (USA) 215/1088 (20.0) (20)
Confirmed inpatient cases in Mexico City 4/18 (22.0) (21)
Confirmed cases and close contacts in Singapore 4/547 (0.7) (18)
Myalgia or arthralgia 32/66 (48.5)
Confirmed inpatient cases in China 43/426 (10.1) (26)
Confirmed inpatient cases in California (USA) 359/1088 (33.0) (20)
Confirmed inpatient cases in Mexico City 8/18 (44.0) (21)
Confirmed cases and close contacts in Singapore 111/547 (20.3) (18)
Outcome Measures
Mechanical ventilation in 
hospitalized patients
11/62 (17.7) Confirmed cases in the United States 4/22 (18.0) (1)
Confirmed inpatient cases in the United States 42/260 (16.1) (3)
Confirmed inpatient cases in Mexico City 12/18 (66.0) (21)
Confirmed inpatient cases in California (USA) 227/915 (25.0) (20)
Confirmed pediatric inpatient cases Toronto (Canada 7/58 (12.0) (22)
ICU admission of hospitalized 
patients
12/62 (19.4) Confirmed cases in the United States 8/22 (36.0) (1)
Confirmed inpatient cases in California (USA) 340/1088 (31.0) (20)
Confirmed pediatric inpatient cases in Toronto (Canada) 12/58(21.0) (22)
Mechanical ventilation in ICU 11/12 (91.7) Confirmed cases in the United States 4/8 (50.0) (1)
Confirmed ICU cases in Australia and New Zealand 456/706 (64.6) (19)
Confirmed inpatient cases in California (USA) 193/297 (65.0) (20)
Confirmed inpatient cases in the United States 42/67 (62.7) (3)
Confirmed pediatric inpatient cases in Toronto (Canada) 7/12(58.0) (22)
Mortality in hospitalized 
patients
2/62 (3.2 ) Confirmed cases in the United States 2/36 (5.0) (1)
Confirmed inpatient cases in the United States 19/272 (7.0) (3)
Confirmed inpatient cases in Mexico City 7/18 (38.8) (21)
Confirmed inpatient cases in California (USA) 118/1088 (11.0) (20)
Confirmed inpatient cases in China 0/426 (0.0) (26)
Confirmed pediatric inpatient cases Toronto (Canada) 0/58 (0.0) (22)
Confirmed cases in Menoufia, Egypt 5/125 (4.0) (27)
Mortality in confirmed cases 2/76 (2.6) Confirmed cases in the United States 2/642 (0.31) (1)
Confirmed cases in Colombia 7/183 (3.8) (29)
Confirmed cases in Menoufia, Egypt 5/400 (1.25) (27)
a Data are presented as No/total No. (%).
Bijani B et al.
Biotech Health Sci. 2015;2(2):e284146
et al. covering both Australia and New Zealand, the 
admission rate was reported to be 2.86/100,000 in-
dividuals (19). This rate in our study was calculated 
at 1.497/100,000 individuals. In Table 4, the rate of as-
sisted ventilation, admission to ICU and mortality is 
compared with the findings of studies reported from 
different countries. It is important to note that due to 
the shortage of ICU beds within the province, the num-
ber of cases admitted to ICUs was probably less than the 
real number of cases with the indications of the need 
for admission to these units in our study. As seen in the 
Table 4, while the rate of assisted ventilation in hospi-
talized cases in our study was lower than most similar 
studies, this rate among the patients admitted to ICUs 
in the present study was clearly higher than that re-
ported from other countries emphasizing the severity 
of cases who were admitted to ICUs. According to sever-
al studies, published in the beginning of the 2009 pan-
demic, mortality rate among the hospitalized patients 
was reported to be high, as demonstrated in a report by 
Perez-Padilla et al. from Mexico in which 38% of hospi-
talized cases with confirmed disease at a tertiary center 
died (21). However, in studies performed later, mortality 
rates of 4% (27) and 11% (20) in hospitalized patients were 
reported. Even in some studies such as the study by Cao 
et al. (26) on 426 confirmed cases (China), Ahmed et al. 
(7) on 356 confirmed cases (Abu Dhabi Emirates) and 
Afrasiabian et al. (8) on 157 confirmed cases (Kurdistan, 
Iran), no case of mortality was reported (7, 26). The mor-
tality rate among the hospitalized patients in the pres-
ent study was 3.2% and this low mortality rate was likely 
to be due to the later occurrence of the epidemics, read-
iness and mobilization of the health care system, and 
also early administration of oseltamivir. Nevertheless, 
the possible inadequacy of laboratory coverage and 
missing cases could not be ruled out. The mortality rate 
of confirmed cases of our study was calculated as 2.63%, 
which was higher than that found by other similar stud-
ies, such as 1.73% in a study from Mexico (21) and 0.31% in 
a study from the USA (1). Likewise, the possible reason 
for this difference is probably due to allocation of sam-
pling only for severely ill people in recent studies. In 
the Eastern Mediterranean region, the mortality rate in 
confirmed cases was calculated as 0.174 per 100,000 in-
dividuals (1019 deaths in 583,000,000 individuals in 22 
countries) (13). In the present study, the mortality rate 
was 0.175 per 100,000 individuals, which is comparable 
to figures reported for the entire region. Regarding the 
prevalence of disease in the younger age group and 
housewives, considering the clinical symptoms such as 
diarrhea, vomiting, cough, myalgia and fever amongst 
these two groups is of prime importance. Moreover, the 
observation that the severe form of novel influenza was 
more obvious among patients with higher BMI, a trend 
not seen in seasonal influenza (28), is of interest and ne-
cessitates greater attention for the management of this 
disease in overweight patients. Meanwhile, allocation 
of sufficient financial resources to ICUs in developing 
countries for severely ill patients is of crucial priority.
5.1. Limitations and Recommendations
Regarding the inclusion of only laboratory confirmed 
cases of pandemic influenza A (H1N1) in the present study, 
and also the possibility of failure in including all cases of 
disease in the study due to lack of laboratory test or prop-
er sampling, the results of the current study could not be 
decisively attributed to all cases of H1N1 influenza. It is 
proposed to undertake studies in order to determine the 
reasons for the emergence of the new outbreak of H1N1 
influenza A in 2015.
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